Next Article in Journal
Identification and Biochemical Characterization of Protein Phosphatase 5 from the Cantharidin-Producing Blister Beetle, Epicauta chinensis
Next Article in Special Issue
Shape and Site Dependent in Vivo Degradation of Mg-Zn Pins in Rabbit Femoral Condyle
Previous Article in Journal
Atorvastatin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Suppressing iNOS Expression and the CTGF (CCN2)/ERK Signaling Pathway
Previous Article in Special Issue
In Vitro Corrosion and Cytocompatibility of ZK60 Magnesium Alloy Coated with Hydroxyapatite by a Simple Chemical Conversion Process for Orthopedic Applications
Int. J. Mol. Sci. 2013, 14(12), 24492-24500; doi:10.3390/ijms141224492
Review

Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease

1,2
,
1,3
,
1
,
1
,
1
,
1
,
5
,
2
,
6
 and
1,4,*
Received: 21 October 2013 / Revised: 3 December 2013 / Accepted: 12 December 2013 / Published: 16 December 2013
(This article belongs to the Special Issue Biodegradable Magnesium Alloys and Implants)
View Full-Text   |   Download PDF [551 KB, uploaded 19 June 2014]   |   Browse Figures

Abstract

The introduction of metallic drug-eluting stents has reduced the risk of restenosis and widened the indications of percutaneous coronary intervention in treatment of coronary artery disease. However, this medical device can induce hypersensitive reaction that interferes with the endothelialization and healing process resulting in late persistent or acquired malapposition of the permanent metallic implant. Delayed endotheliaization and malapposition may lead to late and very late stent thrombosis. Bioresorbable scaffolds (BRS) have been introduced to potentially overcome these limitations, as they provide temporary scaffolding and then disappear, liberating the treated vessel from its cage. Magnesium is an essential mineral needed for a variety of physiological functions in the human body and its bioresorbable alloy has the strength-to-weight ratio comparable with that of strong aluminum alloys and alloy steels. The aim of this review is to present the new developments in Magnesium BRS technology, to describe its clinical application and to discuss the future prospects of this innovative therapy.
Keywords: bioresorbable scaffold; drug-eluting stent; bioabsorbable; biodegradable; coronary artery disease; magnesium bioresorbable scaffold; drug-eluting stent; bioabsorbable; biodegradable; coronary artery disease; magnesium
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Campos, C.M.; Muramatsu, T.; Iqbal, J.; Zhang, Y.-J.; Onuma, Y.; Garcia-Garcia, H.M.; Haude, M.; Lemos, P.A.; Warnack, B.; Serruys, P.W. Bioresorbable Drug-Eluting Magnesium-Alloy Scaffold for Treatment of Coronary Artery Disease. Int. J. Mol. Sci. 2013, 14, 24492-24500.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

Cited By

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert